20 - World Journal of Gastroenterology

Raisch J et al . MicroRNAs in immunity, inflammation and cancerman P. A synonymous variant in IRGM alters a binding sitefor miR-196 and causes deregulation of IRGM-dependentxenophagy in Crohn’s disease. Nat Genet 2011; 43: 242-245[PMID: 21278745]83 Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA,Ayyadurai S, Sitaraman SV, Merlin D. Microbiota modulatehost gene expression via microRNAs. PLoS One 2011; 6:e19293 [PMID: 21559394 DOI: 10.1371/journal.pone.0019293]84 Dalmasso G, Nguyen HT, Yan Y, Laroui H, Srinivasan S,Sitaraman SV, Merlin D. MicroRNAs determine humanintestinal epithelial cell fate. Differentiation 2010; 80: 147-154[PMID: 20638171]85 Nguyen HT, Merlin D. Homeostatic and innate immuneresponses: role of the transmembrane glycoprotein CD98.Cell Mol Life Sci 2012; 69: 3015-3026 [PMID: 22460579 DOI:10.1007/s00018-012-0963-z]86 Nguyen HT, Dalmasso G, Yan Y, Laroui H, Dahan S, MayerL, Sitaraman SV, Merlin D. MicroRNA-7 modulates CD98expression during intestinal epithelial cell differentiation. JBiol Chem 2010; 285: 1479-1489 [PMID: 19892711]87 Hanahan D, Weinberg RA. Hallmarks of cancer: the nextgeneration. Cell 2011; 144: 646-674 [PMID: 21376230]88 Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW.Colorectal cancer. Lancet 2005; 365: 153-165 [PMID: 15639298]89 Dalmay T, Edwards DR. MicroRNAs and the hallmarks ofcancer. Oncogene 2006; 25: 6170-6175 [PMID: 17028596 DOI:10.1038/sj.onc.1209911]90 Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAsen route to the clinic: progress in validating and targetingmicroRNAs for cancer therapy. Nat Rev Cancer 2011; 11:849-864 [PMID: 22113163 DOI: 10.1038/nrc3166]91 Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E,Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M,Croce CM. Human microRNA genes are frequently locatedat fragile sites and genomic regions involved in cancers. ProcNatl Acad Sci USA 2004; 101: 2999-3004 [PMID: 14973191DOI: 10.1073/pnas.0307323101]92 Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, PetroccaF, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, YanaiharaN, Lanza G, Scarpa A, Vecchione A, Negrini M, HarrisCC, Croce CM. A microRNA expression signature of humansolid tumors defines cancer gene targets. Proc Natl Acad SciUSA 2006; 103: 2257-2261 [PMID: 16461460]93 Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, PeckD, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNAexpression profiles classify human cancers. Nature 2005; 435:834-838 [PMID: 15944708 DOI: 10.1038/nature03702]94 Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST,Patel T. MicroRNA-21 regulates expression of the PTENtumor suppressor gene in human hepatocellular cancer. Gastroenterology2007; 133: 647-658 [PMID: 17681183]95 Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED,Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, LiuCG, Calin GA, Croce CM, Harris CC. MicroRNA expressionprofiles associated with prognosis and therapeutic outcomein colon adenocarcinoma. JAMA 2008; 299: 425-436 [PMID:18230780]96 Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, ColburnNH, Post S, Allgayer H. MicroRNA-21 (miR-21) posttranscriptionallydownregulates tumor suppressor Pdcd4and stimulates invasion, intravasation and metastasis incolorectal cancer. Oncogene 2008; 27: 2128-2136 [PMID:17968323]97 Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, HennessyE, Curran CE, Curran S, Smith MJ, Regan M, McAnenaOJ, Kerin MJ. MicroRNA-21 and PDCD4 expression incolorectal cancer. Eur J Surg Oncol 2011; 37: 597-603 [PMID:21546206]98 Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T.Clinicopathological and prognostic value of microRNA-21and microRNA-155 in colorectal cancer. Oncology 2010; 79:313-320 [PMID: 21412018]99 Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, GommeauxJ, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A,Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M,Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ.Tumor protein 53-induced nuclear protein 1 expression isrepressed by miR-155, and its restoration inhibits pancreatictumor development. Proc Natl Acad Sci USA 2007; 104:16170-16175 [PMID: 17911264]100 Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F,Shibata K, Ishii H, Sugihara K, Doki Y, Mori M. Microarrayanalysis of colorectal cancer stromal tissue reveals upregulationof two oncogenic miRNA clusters. Clin Cancer Res 2012;18: 3054-3070 [PMID: 22452939 DOI: 10.1158/1078-0432.CCR-11-1078]101 Stefani G, Slack FJ. Small non-coding RNAs in animal development.Nat Rev Mol Cell Biol 2008; 9: 219-230 [PMID:18270516]102 Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y,Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, StephensRM, Croce CM, Ambs S. MicroRNA-106b-25 cluster expressionis associated with early disease recurrence and targetscaspase-7 and focal adhesion in human prostate cancer.Oncogene 2012; Epub ahead of print [PMID: 22986525 DOI:10.1038/onc.2012.424]103 Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforminggrowth factor beta signaling. Cancer Res 2008; 68: 8191-8194[PMID: 18922889]104 Mendell JT. miRiad roles for the miR-17-92 cluster indevelopment and disease. Cell 2008; 133: 217-222 [PMID:18423194]105 Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T,Ueda S, Takanashi M, Kuroda M. miR-92 is a key oncogeniccomponent of the miR-17-92 cluster in colon cancer. CancerSci 2011; 102: 2264-2271 [PMID: 21883694 DOI: 10.1111/j.1349-7006.2011.02081.x]106 Dews M, Homayouni A, Yu D, Murphy D, Sevignani C,Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT,Thomas-Tikhonenko A. Augmentation of tumor angiogenesisby a Myc-activated microRNA cluster. Nat Genet 2006;38: 1060-1065 [PMID: 16878133]107 Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAsin vascular diseases, inflammation, and angiogenesis. CardiovascRes 2008; 79: 581-588 [PMID: 18550634]108 Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K,Uetake H, Sugihara K, Mori M. Over- and under-expressedmicroRNAs in human colorectal cancer. Int J Oncol 2009; 34:1069-1075 [PMID: 19287964]109 Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H,Galle PR, Moehler M, Gockel I. High miR-196a levels promotethe oncogenic phenotype of colorectal cancer cells.World J Gastroenterol 2009; 15: 2089-2096 [PMID: 19418581]110 Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D,Bednarikova M, Nenutil R, Vyzula R. Altered expression ofmiR-21, miR-31, miR-143 and miR-145 is related to clinicopathologicfeatures of colorectal cancer. Oncology 2007; 72:397-402 [PMID: 18196926]111 Schee K, Fodstad Ø, Flatmark K. MicroRNAs as biomarkersin colorectal cancer. Am J Pathol 2010; 177: 1592-1599 [PMID:20829435]112 Zhou W, Li X, Liu F, Xiao Z, He M, Shen S, Liu S. MiR-135a promotes growth and invasion of colorectal cancer viametastasis suppressor 1 in vitro. Acta Biochim Biophys Sin(Shanghai) 2012; 44: 838-846 [PMID: 23017832]113 Esquela-Kerscher A, Slack FJ. OncomiRs - microRNAswith a role in cancer. Nat Rev Cancer 2006; 6: 259-269 [PMID:16557279]WJG|www.wjgnet.com2995 May 28, 2013|Volume 19|Issue 20|